⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TCRX News
TScan Therapeutics, Inc. Common Stock
TScan Therapeutics Announces First Patient Dosed in Phase 3 ALLOHA-2™, a Pivotal Trial Evaluating TSC-101 in Patients with Heme Malignancies
globenewswire.com
TCRX
Hyperscale Data Centers Lead Growth in Global Cable Market
globenewswire.com
AMZN
MSFT
GOOGL
META
GLW
TCRX
BDC
TScan Therapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
globenewswire.com
TCRX
Form 8-K
sec.gov
TCRX
TScan Therapeutics Announces Positive Initial Data from Cohort C of Ongoing ALLOHA™ Phase 1 Study Evaluating TSC-101 in Patients with Heme Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation
globenewswire.com
TCRX
Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies
businesswire.com
TCRX
Form 8-K
sec.gov
TCRX
TailorCare Recognized as one of the Best Places to Work in Healthcare in 2026 for Two Years in a Row
globenewswire.com
TCRX
ThoroughCare Expands Remote Patient Monitoring with Withings Integration
businesswire.com
TCRX
Form 8-K
sec.gov
TCRX